PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Herbs	92.69B	63.65B	21.06B	15.32B	24.33B
Herbs Growth	45.61%	202.18%	37.53%	-37.04%	-
Cosmetics	36.97B	26.57B	23.90B	15.45B	13.31B
Cosmetics Growth	39.15%	11.16%	54.66%	16.08%	-
Functional and Botanical Drinks	30.46B	30.41B	11.97B	7.73B	212.42M
Functional and Botanical Drinks Growth	0.19%	154.12%	54.87%	3537.31%	-
Total	160.12B	120.63B	56.93B	38.50B	37.85B
Total Growth	32.74%	111.89%	47.89%	1.70%	-

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Indonesia	160.12B	120.63B	56.93B	38.50B	37.85B
Indonesia Growth	32.74%	111.89%	47.89%	1.70%	-
Total	160.12B	120.63B	56.93B	38.50B	37.85B
Total Growth	32.74%	111.89%	47.89%	1.70%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error